Strand Therapeutics

About Strand Therapeutics

Strand Therapeutics is a biotechnology company developing a platform for programmable messenger RNA (mRNA) therapeutics. The company focuses on creating autonomous, long-acting mRNA medicines that can sense cell types and activate only in diseased cells, thereby increasing therapeutic precision and window. Its pipeline targets cancer and other life-threatening diseases with programmable genetic circuits embedded in mRNA to control location, timing, and duration of protein expression. Strand emphasizes a directed approach to bioengineering and synthetic biology, aiming to deliver potentially curative treatments.